Healthcare provider profile · identity verified

Adefunke Adedipe, MD

Family Practice · LORAIN, OH · NPI 1114313590

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	352	84
Atorvastatin Calcium	Atorvastatin Calcium	350	100
Omeprazole	Omeprazole	322	75
Amlodipine Besylate	Amlodipine Besylate	244	69
Gabapentin	Gabapentin	221	53
Albuterol Sulfate Hfa	Albuterol Sulfate	204	53
Lisinopril	Lisinopril	181	52
Pravastatin Sodium	Pravastatin Sodium	172	47
Losartan Potassium	Losartan Potassium	157	37
Simvastatin	Simvastatin	154	40
Sertraline Hcl	Sertraline Hcl	146	40
Metoprolol Succinate	Metoprolol Succinate	135	37
Hydrochlorothiazide	Hydrochlorothiazide	126	29
Tizanidine Hcl	Tizanidine Hcl	112	36
Trazodone Hcl	Trazodone Hcl	111	30
Pantoprazole Sodium	Pantoprazole Sodium	108	25
Metformin Hcl	Metformin Hcl	103	26
Montelukast Sodium	Montelukast Sodium	103	19
Tamsulosin Hcl	Tamsulosin Hcl	103	20
Famotidine	Famotidine	102	23
Furosemide	Furosemide	97	31
Meloxicam	Meloxicam	91	20
Buspirone Hcl	Buspirone Hcl	90	19
Fluticasone Propionate	Fluticasone Propionate	88	37
Nystatin	Nystatin	85	25
Metoprolol Tartrate	Metoprolol Tartrate	80	18
Rosuvastatin Calcium	Rosuvastatin Calcium	75	26
Citalopram Hbr	Citalopram Hydrobromide	74	suppressed
Potassium Chloride	Potassium Chloride	70	28
Oxybutynin Chloride Er	Oxybutynin Chloride	69	suppressed
Carvedilol	Carvedilol	68	22
Baclofen	Baclofen	67	suppressed
Atenolol	Atenolol	66	16
Methylprednisolone	Methylprednisolone	66	52
Bupropion Xl	Bupropion Hcl	64	suppressed
Duloxetine Hcl	Duloxetine Hcl	64	14
Ibuprofen	Ibuprofen	62	24
Metformin Hcl Er	Metformin Hcl	62	18
Fluoxetine Hcl	Fluoxetine Hcl	56	13
Hydroxyzine Hcl	Hydroxyzine Hcl	54	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	53	15
Synthroid	Levothyroxine Sodium	51	14
Triamcinolone Acetonide	Triamcinolone Acetonide	51	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	51	14
Alendronate Sodium	Alendronate Sodium	45	11
Allopurinol	Allopurinol	44	14
Meclizine Hcl	Meclizine Hcl	41	14
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Topiramate	Topiramate	39	suppressed
Hydrocortisone	Hydrocortisone	38	11
Januvia	Sitagliptin Phosphate	38	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	27
Clopidogrel	Clopidogrel Bisulfate	36	suppressed
Fluconazole	Fluconazole	36	15
Mirtazapine	Mirtazapine	36	suppressed
Chlorthalidone	Chlorthalidone	35	suppressed
Mupirocin	Mupirocin	34	suppressed
Pregabalin	Pregabalin	34	suppressed
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	13
Doxycycline Hyclate	Doxycycline Hyclate	32	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Ozempic	Semaglutide	31	suppressed
Donepezil Hcl	Donepezil Hcl	30	suppressed
Glycopyrrolate	Glycopyrrolate	30	suppressed
Levetiracetam	Levetiracetam	29	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Azithromycin	Azithromycin	28	24
Glimepiride	Glimepiride	28	suppressed
Lovastatin	Lovastatin	28	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Ketoconazole	Ketoconazole	27	suppressed
Risperidone	Risperidone	27	suppressed
Eliquis	Apixaban	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Valsartan	Valsartan	25	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	24	suppressed
Finasteride	Finasteride	24	suppressed
Irbesartan	Irbesartan	24	suppressed
Nitroglycerin	Nitroglycerin	24	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Varenicline Tartrate	Varenicline Tartrate	20	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	20	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Naproxen	Naproxen	18	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	17	suppressed
Glipizide	Glipizide	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	13
Tramadol Hcl	Tramadol Hcl	16	suppressed
Ursodiol	Ursodiol	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Levofloxacin	Levofloxacin	15	13
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Ammonium Lactate	Ammonium Lactate	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	14	suppressed
Epinephrine	Epinephrine	14	suppressed
Prednisone	Prednisone	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Aptiom	Eslicarbazepine Acetate	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Indapamide	Indapamide	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Klor-Con M10	Potassium Chloride	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Primidone	Primidone	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Vilazodone Hcl	Vilazodone Hcl	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Ibu	Ibuprofen	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Nabumetone	Nabumetone	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error